View Older Stories View More Recent Stories

Nov 7, 2024 10:00AM Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Nov 1, 2024 07:45AM Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Oct 24, 2024 08:00AM Phio Pharmaceuticals Announces Upcoming Presentation at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Oct 18, 2024 01:30PM Correction to Registration Link to Access Phio Pharmaceuticals' Presentation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Oct 18, 2024 08:00AM Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-deal Roadshow Series
Oct 16, 2024 08:05AM Phio Pharmaceuticals (PHIO) Presenting Data on PH-894
Oct 16, 2024 08:00AM Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference
Oct 7, 2024 08:00AM Phio Announces Data Showcasing INTASYL's Role in Helping Immune Cells Target and Kill Cancer Cells
Oct 2, 2024 08:00AM Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Oct 1, 2024 08:00AM Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference
Sep 25, 2024 08:00AM INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society
Sep 17, 2024 08:00AM Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Sep 16, 2024 08:00AM Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA
Sep 9, 2024 07:00AM Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Aug 29, 2024 08:30AM Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
Aug 14, 2024 05:00PM Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
Aug 6, 2024 08:00AM Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio's Patented INTASYL Compound
Aug 1, 2024 08:02AM Phio Pharmaceuticals (PHIO) Appoints Robert M. Infarinato as CFO
Aug 1, 2024 08:00AM Phio Pharmaceuticals Announces New Chief Financial Officer
Jul 12, 2024 08:03AM Phio Pharmaceuticals (PHIO) to Receive $3.1M Gross Proceeds from Warrant Exercise
Jul 12, 2024 08:00AM Phio Pharmaceuticals Announces Exercise of Warrants for $3.1 Million Gross Proceeds
Jul 8, 2024 08:02AM Phio Pharmaceuticals (PHIO) Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762
Jul 8, 2024 08:00AM Phio Pharmaceuticals Announces Addition of Clinical Trial Site for its Phase 1b study of PH-762
Jul 5, 2024 08:02AM Phio Pharmaceuticals Corp. (PHIO) Terminates Share Purchase Agreement with Triton Funds
Jul 5, 2024 08:00AM Phio Pharmaceuticals Terminates Share Purchase Agreement with Triton Funds
Jul 2, 2024 11:47AM Phio Pharmaceuticals Corp. (PHIO) Announces Reverse Stock Split
Jul 2, 2024 11:45AM Phio Pharmaceuticals Announces Reverse Stock Split
Jun 18, 2024 07:32AM Phio Pharmaceuticals Corp. (PHIO) Announces New Patent for INTASYL
Jun 18, 2024 07:30AM Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging
View More Recent Stories View Older Stories